King Mohammed VI has promoted Professor Kamal Doghmi, director general of the Moroccan Agency for Blood and Its Derivatives, to brigadier general doctor. The promotion came during the 27th Throne Day celebrations as part of the 2026 military promotion list. It includes officers from the Royal Armed Forces, the Royal Gendarmerie, the Royal Guard and the Auxiliary Forces.
Professor Doghmi received his new rank during an oath-taking ceremony at the Royal Palace in Tetouan. Crown Prince Moulay El Hassan and Prince Moulay Rachid attended the event.
The ceremony also welcomed graduates from military, paramilitary and civilian training schools. King Mohammed VI named the 2026 graduating class “Laayoune.”
Professor Doghmi moved up from senior colonel doctor, the rank below brigadier general doctor in the military.
He is a clinical haematologist and heads the Clinical Haematology Department at Mohammed V Military Teaching Hospital in Rabat. He also teaches haematology at the Faculty of Medicine and Pharmacy at Mohammed V University.
Professor Doghmi earned his medical degree in Rabat before completing specialist training in clinical haematology at the Val-de-Grâce Military Hospital in France. He also holds a postgraduate diploma in clinical haematology from Paris Descartes University.
His academic career began in 2004 as an assistant professor. He became an associate professor in 2009 and a full professor in 2013. He took charge of the Clinical Haematology Department at Mohammed V Military Teaching Hospital in 2018. A year later, he became director of the specialist diploma programme and head of the teaching and research unit in clinical haematology at the Faculty of Medicine and Pharmacy.
King Mohammed VI appointed Professor Doghmi as director general of the Moroccan Agency for Blood and Its Derivatives on 18 October 2024. The appointment came during a ministerial council that also named the heads of several new health institutions created under the country’s healthcare reform.
The agency started work in January 2025 after its first board meeting approved its annual programme, budget and organisational structure.
Law 11.22 created the agency as an independent public institution. It plans and manages the national blood policy. Its work includes collecting blood donations, testing blood, preparing and storing blood products, and supplying hospitals across the public and private sectors.
The agency also licenses blood storage units, oversees blood transfusion services, helps set blood bag prices and supports research and training. It replaced the National Blood Transfusion Centre and the regional blood centres with one national organisation.
Professor Doghmi is leading work to improve the blood transfusion system. Current projects include better stock management, common safety standards, digital tracking of blood supplies, modernising regional centres and reducing gaps in access to blood products across the country.
The Ministry of Digital Transition and Administration Reform met Professor Doghmi in May 2025 to discuss plans to digitise the agency’s services and improve its operations.
